Webinar Will Examine Environmental Toxins and Brain Health
Experts will discuss new findings on environmental microplastics and their potential impact on cognitive decline.
Updated on Oct. 5, 2026 in Alzheimer’s
Live Poll
Will targeted toxin removal treatments become a standard approach for preventing cognitive decline by 2030?
MDLifespan is hosting a webinar on October 15, 2026, to explore the connection between environmental toxins and neurological health. The event provides context on emerging research into how pollutants, including microplastics, may influence Alzheimer’s disease markers.
Why it matters
Researchers are investigating how environmental exposures might contribute to cognitive decline, shifting the focus toward potential blood-based interventions. This session aims to clarify current findings regarding the accumulation of plastics in brain tissue.
A 2025 Nature Medicine study found higher concentrations of microplastics in human brain tissue than in liver or kidney tissue. Separately, the AMBAR clinical trial of 347 patients showed significant functional and cognitive improvements, while a 2026 study evaluated microplastic levels post-exchange.
The players
MDLifespan
A health organization focusing on longevity and the impact of environmental toxins on cognitive health.
The details
Therapeutic Plasma Exchange (TPE) functions by removing a patient's plasma and replacing it with a solution containing albumin, effectively filtering the blood before returning cellular components. By reducing circulating substances in the bloodstream, researchers are studying whether this mechanical intervention can slow disease progression. Preliminary evidence suggests this process may also reduce circulating microplastic levels, a finding currently being examined alongside established Alzheimer’s biomarkers.
Timeline
A 2025 study analyzed the presence of plastics in human tissue.
The Journal of Clinical Apheresis published TPE findings in 2026.
The MDLifespan webinar takes place on October 15, 2026, at 4 p.m. ET.
Health Landscape
This development marks a shift in how medical science addresses cognitive health by integrating environmental toxicology with blood-based therapies. It builds directly upon the AMBAR clinical trial to explore whether mechanical blood purification can modify disease-related decline.
Residents should view these findings as a developing area of research rather than a clinical recommendation. Any questions regarding cognitive health or the relevance of environmental exposures should be raised during a standard checkup with your physician.
The takeaway
Emerging research highlights a possible link between environmental microplastics and brain health. Stay informed by tracking ongoing studies on blood-based interventions, and consult your physician to discuss any concerns regarding cognitive changes.
What happens next
The MDLifespan webinar will be held on October 15, 2026, at 4 p.m. ET.
Further reading
For more on the current understanding of memory care, visit our section on Alzheimer’s.
Source note: This article includes information reported by The Manila times.
Live Poll
Will targeted toxin removal treatments become a standard approach for preventing cognitive decline by 2030?
